ADMA
ADMA BIOLOGICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ADMA BIOLOGICS INC (ADMA) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$57.33M; the largest are Stanley Druckenmiller, Ken Griffin, Izzy Englander. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 5 trimmed, 1 closed. 8 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders72 also report options
Congress trades8
Price$9.96vs quarter-end+19.00%
Sectors0
This quarter's moves
Top holderNew1
Added1
Trimmed / sold6
Stanley DruckenmillerCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $23.30M0.5% of portfolio2,784,1102026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Stanley Druckenmiller | $23.30M | 0.5% | Add |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $1.06M— of portfolio126,3002026 Q2
Value $1.04M— of portfolio123,9002026 Q2
Value $419.3K— of portfolio50,1002026 Q2
Value $293.8K— of portfolio35,1002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $1.06M | — | — |
| Ken GriffinPUT | $1.04M | — | — |
| Steven CohenCALL | $419.3K | — | — |
| Steven CohenPUT | $293.8K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.